Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome

Nature volume 499, pages 97–101 (2013)Cite this article

Subjects

A Corrigendum to this article was published on 29 January 2014

Abstract

Obesity has become more prevalent in most developed countries over the past few decades, and is increasingly recognized as a major risk factor for several common types of cancer1. As the worldwide obesity epidemic has shown no signs of abating2, better understanding of the mechanisms underlying obesity-associated cancer is urgently needed. Although several events were proposed to be involved in obesity-associated cancer1,3, the exact molecular mechanisms that integrate these events have remained largely unclear. Here we show that senescence-associated secretory phenotype (SASP)4,5 has crucial roles in promoting obesity-associated hepatocellular carcinoma (HCC) development in mice. Dietary or genetic obesity induces alterations of gut microbiota, thereby increasing the levels of deoxycholic acid (DCA), a gut bacterial metabolite known to cause DNA damage6. The enterohepatic circulation of DCA provokes SASP phenotype in hepatic stellate cells (HSCs)7, which in turn secretes various inflammatory and tumour-promoting factors in the liver, thus facilitating HCC development in mice after exposure to chemical carcinogen. Notably, blocking DCA production or reducing gut bacteria efficiently prevents HCC development in obese mice. Similar results were also observed in mice lacking an SASP inducer8 or depleted of senescent HSCs, indicating that the DCA–SASP axis in HSCs has key roles in obesity-associated HCC development. Moreover, signs of SASP were also observed in the HSCs in the area of HCC arising in patients with non-alcoholic steatohepatitis3, indicating that a similar pathway may contribute to at least certain aspects of obesity-associated HCC development in humans as well. These findings provide valuable new insights into the development of obesity-associated cancer and open up new possibilities for its control.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy article

Get time limited or full article access on ReadCube.

$32.00

Buy

All prices are NET prices.

Figure 1: Cellular senescence in HSCs.
Figure 2: IL-1β deficiency alleviates obesity-induced HCC development.
Figure 3: Antibiotics treatments alleviate obesity-induced HCC development.
Figure 4: Bacterial metabolite promotes obesity-induced HCC development.

Accession codes

Accessions

DDBJ/GenBank/EMBL

Data deposits

Bacterial 16S rRNA amplicon sequence data have been deposited in DDBJ (http://www.ddbj.nig.ac.jp/index-e.html) with the accession number DRA000952.

References

  1. Khandekar, M. J., Cohen, P. & Spiegelman, B. M. Molecular mechanisms of cancer development in obesity. Nature Rev. Cancer 11, 886–895 (2011)

    Article  CAS  Google Scholar 

  2. Calle, E. E. & Kaaks, R. Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms. Nature Rev. Cancer 4, 579–591 (2004)

    Article  CAS  Google Scholar 

  3. Sun, B. & Karin, M. Obesity, inflammation, and liver cancer. J. Hepatol. 56, 704–713 (2012)

    Article  CAS  Google Scholar 

  4. Coppé, J. P. et al. Senescence-associated secretory phenotypes reveal cell-nonautonomous functions of oncogenic RAS and the p53 tumor suppressor. PLoS Biol. 6, 2853–2868 (2008)

    Article  Google Scholar 

  5. Kuilman, T. & Peeper, D. S. Senescence-messaging secretome: SMS-ing cellular stress. Nature Rev. Cancer 9, 81–94 (2009)

    Article  CAS  Google Scholar 

  6. Ridlon, J. M., Kang, D. J. & Hylemon, P. B. Bile salt biotransformations by human intestinal bacteria. J. Lipid Res. 47, 241–259 (2006)

    Article  CAS  Google Scholar 

  7. Friedman, S. L. Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver. Physiol. Rev. 88, 125–172 (2008)

    Article  CAS  Google Scholar 

  8. Orjalo, A. V., Bhaumik, D., Gengler, B. K., Scott, G. K. & Campisi, J. Cell surface-bound IL-1α is an upstream regulator of the senescence-associated IL-6/IL-8 cytokine network. Proc. Natl Acad. Sci. USA 106, 17031–17036 (2009)

    Article  ADS  CAS  Google Scholar 

  9. Collado, M. & Serrano, M. Senescence in tumours: evidence from mice and humans. Nature Rev. Cancer 10, 51–57 (2010)

    Article  CAS  Google Scholar 

  10. Kuilman, T., Michaloglou, C., Mooi, W. J. & Peeper, D. S. The essence of senescence. Genes Dev. 24, 2463–2479 (2010)

    Article  CAS  Google Scholar 

  11. Krizhanovsky, V. et al. Senescence of activated stellate cells limits liver fibrosis. Cell 134, 657–667 (2008)

    Article  CAS  Google Scholar 

  12. Kang, T. W. et al. Senescence surveillance of pre-malignant hepatocytes limits liver cancer development. Nature 479, 547–551 (2011)

    Article  ADS  CAS  Google Scholar 

  13. Park, E. J. et al. Dietary and genetic obesity promote liver inflammation and tumorigenesis by enhancing IL-6 and TNF expression. Cell 140, 197–208 (2010)

    Article  CAS  Google Scholar 

  14. Newell, P. et al. Ras pathway activation in hepatocellular carcinoma and anti-tumoral effect of combined sorafenib and rapamycin in vivo. J. Hepatol. 51, 725–733 (2009)

    Article  CAS  Google Scholar 

  15. Serrano, M. et al. Role of the INK4a locus in tumor suppression and cell mortality. Cell 85, 27–37 (1996)

    Article  CAS  Google Scholar 

  16. Ohtani, N. et al. Visualizing the dynamics of p21Waf1/Cip1 cyclin-dependent kinase inhibitor expression in living animals. Proc. Natl Acad. Sci. USA 104, 15034–15039 (2007)

    Article  ADS  CAS  Google Scholar 

  17. Coppé, J.-P. et al. Tumor suppressor and aging biomarker p16INK4a induces cellular senescence without the associated inflammatory secretory phenotype. J. Biol. Chem. 286, 36396–36403 (2011)

    Article  Google Scholar 

  18. Sato, Y. et al. Resolution of liver cirrhosis using vitamin A-coupled liposomes to deliver siRNA against a collagen-specific chaperone. Nature Biotechnol. 26, 431–442 (2008)

    Article  CAS  Google Scholar 

  19. Ley, R. E., Turnbaugh, P. J., Klein, S. & Gordon, J. I. Microbial ecology: human gut microbes associated with obesity. Nature 444, 1022–1023 (2006)

    Article  ADS  CAS  Google Scholar 

  20. Dapito, D. H. et al. Promotion of hepatocellular carcinoma by the intestinal microbiota and TLR4. Cancer Cell 21, 504–516 (2012)

    Article  CAS  Google Scholar 

  21. Payne, C. M. et al. Deoxycholate induces mitochondrial oxidative stress and activates NF-κB through multiple mechanisms in HCT-116 colon epithelial cells. Carcinogenesis 28, 215–222 (2007)

    Article  CAS  Google Scholar 

  22. Takahashi, A. et al. DNA damage signaling triggers degradation of histone methyltransferases through APC/CCdh1 in senescent cells. Mol. Cell 45, 123–131 (2012)

    Article  CAS  Google Scholar 

  23. McGarr, S. E., Ridlon, J. M. & Hylemon, P. B. Diet, anaerobic bacterial metabolism, and colon cancer: a review of the literature. J. Clin. Gastroenterol. 39, 98–109 (2005)

    PubMed  Google Scholar 

  24. Kitazawa, S. et al. Enhanced preneoplastic liver lesion development under ‘selection pressure’ conditions after administration of deoxycholic or lithocholic acid in the initiation phase in rats. Carcinogenesis 11, 1323–1328 (1990)

    Article  CAS  Google Scholar 

  25. Minamida, K., Ohashi, M., Hara, H., Asano, K. & Tomita, F. Effects of ingestion of difructose anhydride III (DFA III) and the DFA III-assimilating bacterium Ruminococcus productus on rat intestine. Biosci. Biotechnol. Biochem. 70, 332–339 (2006)

    Article  CAS  Google Scholar 

  26. Beuers, U. Drug insight: mechanisms and sites of action of ursodeoxycholic acid in cholestasis. Nat. Clin. Pract. Gastroenterol. Hepatol. 3, 318–328 (2006)

    Article  CAS  Google Scholar 

  27. Ridlon, J. M. & Hylemon, P. B. Identification and characterization of two bile acid coenzyme A transferases from Clostridium scindens, a bile acid 7α-dehydroxylating intestinal bacterium. J. Lipid Res. 53, 66–76 (2012)

    Article  CAS  Google Scholar 

  28. Schnabl, B., Purbeck, G. A., Choi, Y. H., Hagedorn, C. H. & Brenner, D. A. Replicative senescence of activated human hepatic stellate cells is accompanied by a pronounced inflammatory but less fibrogenic phenotype. Hepatology 37, 653–664 (2003)

    Article  CAS  Google Scholar 

  29. Takuma, Y. & Nouso, K. Nonalcoholic steatohepatitis-associated hepatocellular carcinoma: our case series and literature review. World J. Gastroenterol. 16, 1436–1441 (2010)

    Article  CAS  Google Scholar 

  30. Rafter, J. J. et al. Cellular toxicity of fecal water depends on diet. Am. J. Clin. Nutr. 45, 559–563 (1987)

    Article  CAS  Google Scholar 

  31. Horai, R. et al. Production of mice deficient in genes for interleukin (IL)-1α, IL-1β, IL-1α/β, and IL-1 receptor antagonist shows that IL-1β is crucial in turpentine-induced fever development and glucocorticoid secretion. J. Exp. Med. 187, 1463–1475 (1998)

    Article  CAS  Google Scholar 

  32. Reagan-Shaw, S., Nihal, M. & Ahmad, N. Dose translation from animal to human studies revisited. FASEB J. 22, 659–661 (2008)

    Article  CAS  Google Scholar 

  33. Yamakoshi, K. et al. Real-time in vivo imaging of p16Ink4a reveals cross talk with p53. J. Cell Biol. 186, 393–407 (2009)

    Article  CAS  Google Scholar 

  34. Collins, M. D. et al. The phylogeny of the genus Clostridium: proposal of five new general and eleven new species combinations. Int. J. Syst. Bacteriol. 44, 812–826 (1994)

    Article  CAS  Google Scholar 

  35. Atarashi, K. et al. Induction of colonic regulatory T cells by indigenous Clostridium species. Science 331, 337–341 (2011)

    Article  ADS  CAS  Google Scholar 

  36. Song, Y., Liu, C. & Finegold, S. M. Real-time PCR quantitation of clostridia in feces of autistic children. Appl. Environ. Microbiol. 70, 6459–6465 (2004)

    Article  CAS  Google Scholar 

  37. Ooga, T. et al. Metabolomic anatomy of an animal model revealing homeostatic imbalances in dyslipidaemia. Mol. Biosyst. 7, 1217–1223 (2011)

    Article  CAS  Google Scholar 

  38. Muto, A. et al. Detection of Δ4-3-oxo-steroid 5β-reductase deficiency by LC–ESI-MS/MS measurement of urinary bile acids. J. Chromatogr. B 900, 24–31 (2012)

    Article  CAS  Google Scholar 

  39. Sekiya, Y. et al. Down-regulation of cyclin E1 expression by microRNA-195 accounts for interferon-β-induced inhibition of hepatic stellate cell proliferation. J. Cell. Physiol. 226, 2535–2542 (2011)

    Article  CAS  Google Scholar 

Download references

Acknowledgements

The authors thank M. Oshima for suggestions in antibiotics treatment and members of the Hara laboratory for discussion during the preparation of this manuscript. This work was supported by grants from Japan Science and Technology Agency (JST), Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT), Ministry of Health, Labour and Welfare of Japan (MHLW), Uehara Memorial Foundation and Takeda Science Foundation. S.Y. was partly supported by a postdoctoral fellowship from the Japan Society for Promotion of Science (JSPS). T.M.L. was partly supported by an international scholarship from the Ajinomoto Scholarship Foundation.

Author information

Author notes

  1. Shin Yoshimoto and Naoko Ohtani: These authors contributed equally to this work.

Authors and Affiliations

  1. Division of Cancer Biology, Cancer Institute, Japanese Foundation for Cancer Research, Koto-ku, Tokyo 135-8550, Japan,

    Shin Yoshimoto, Tze Mun Loo, Seidai Sato, Eiji Hara & Naoko Ohtani

  2. CREST, Japan Science and Technology Agency, Kawaguchi, Saitama 332-0012, Japan,

    Shin Yoshimoto, Tze Mun Loo, Seidai Sato, Kenya Honda & Eiji Hara

  3. Department of Applied Biological Science, Tokyo University of Science, Noda, Chiba 278-8510, Japan,

    Tze Mun Loo

  4. Research Center for Allergy and Immunology, RIKEN, Yokohama, Kanagawa 230-0045, Japan,

    Koji Atarashi & Kenya Honda

  5. PRESTO, Japan Science and Technology Agency, Kawaguchi, Saitama 332-0012, Japan,

    Koji Atarashi & Naoko Ohtani

  6. Division of Pathology, Cancer Institute, Japanese Foundation for Cancer Research, Koto-ku, Tokyo 135-8550, Japan,

    Hiroaki Kanda & Yuichi Ishikawa

  7. Institute for Genome Research, University of Tokushima, Tokushima 770-8503, Japan,

    Seiichi Oyadomari

  8. Research Institute for Biological Science, Tokyo University of Science, Noda, Chiba 278-8510, Japan,

    Yoichiro Iwakura

  9. Graduate School of Frontier Sciences, University of Tokyo, Kashiwa, Chiba 277-8561, Japan,

    Kenshiro Oshima & Masahira Hattori

  10. School of Veterinary Medicine, Azabu University, Sagamihara, Kanagawa 229-8501, Japan,

    Hidetoshi Morita

Authors
  1. Shin Yoshimoto
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Tze Mun Loo
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Koji Atarashi
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Hiroaki Kanda
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Seidai Sato
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Seiichi Oyadomari
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Yoichiro Iwakura
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Kenshiro Oshima
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Hidetoshi Morita
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Masahira Hattori
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Kenya Honda
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Yuichi Ishikawa
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. Eiji Hara
    View author publications

    You can also search for this author in PubMed Google Scholar

  14. Naoko Ohtani
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

E.H. and N.O. designed the experiments, analysed the data and wrote the manuscript. N.O., S.Y. and T.M.L. performed obesity-induced liver cancer experiments. K.A., K.O., H.M., M.H. and K.H. performed bacterial genome data analysis. H.K., S.S. and Y.I. performed histopathological analysis of mouse and human liver cancer specimens. S.O. performed metabolite analysis. Y.I. provided Il-1β−/− mice. E.H. oversaw the projects.

Corresponding author

Correspondence to Eiji Hara.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Supplementary information

Supplementary Figures

This file contains Supplementary Figures 1-16 and Supplementary References. (PDF 17390 kb)

PowerPoint slides

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Yoshimoto, S., Loo, T., Atarashi, K. et al. Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome. Nature 499, 97–101 (2013). https://doi.org/10.1038/nature12347

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nature12347

This article is cited by

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.

Search

Advanced search

Quick links

Nature Briefing: Cancer

Sign up for the Nature Briefing: Cancer newsletter — what matters in cancer research, free to your inbox weekly.

Get what matters in cancer research, free to your inbox weekly. Sign up for Nature Briefing: Cancer